Published in J Nucl Med on November 01, 1993
EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2. Eur J Nucl Med Mol Imaging (2009) 1.49
Measurement of cerebral perfusion with arterial spin labeling: Part 2. Applications. J Int Neuropsychol Soc (2007) 1.42
Quantitative analysis of simultaneous EEG features during PET studies for childhood partial epilepsy. Yonsei Med J (2013) 0.76
WONOEP appraisal: Molecular and cellular biomarkers for epilepsy. Epilepsia (2016) 0.76
Comparison of [18F]FDG-PET, [99mTc]-HMPAO-SPECT, and [123I]-iomazenil-SPECT in localising the epileptogenic cortex. J Neurol Neurosurg Psychiatry (1997) 0.75
Name calling in the temporal lobe. Epilepsy Curr (2009) 0.75
Automated image registration: I. General methods and intrasubject, intramodality validation. J Comput Assist Tomogr (1998) 12.47
Isolation and characterization of full-length cDNA clones for human alpha-, beta-, and gamma-actin mRNAs: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol (1983) 11.06
Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med (1994) 8.03
Cortical mechanisms of human imitation. Science (1999) 7.89
Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp (1994) 7.28
Automated image registration: II. Intersubject validation of linear and nonlinear models. J Comput Assist Tomogr (1998) 6.75
Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med (2000) 6.72
Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res (1984) 6.56
Rapid automated algorithm for aligning and reslicing PET images. J Comput Assist Tomogr (1992) 6.39
MRI-PET registration with automated algorithm. J Comput Assist Tomogr (1993) 5.96
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08
Positron emission tomography study of human brain functional development. Ann Neurol (1987) 4.89
Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc Natl Acad Sci U S A (2000) 4.85
Area V5 of the human brain: evidence from a combined study using positron emission tomography and magnetic resonance imaging. Cereb Cortex (1993) 4.79
Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport (2000) 4.50
Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease. JAMA (1995) 4.02
The structure of cell adhesion molecule uvomorulin. Insights into the molecular mechanism of Ca2+-dependent cell adhesion. EMBO J (1987) 4.00
Hippocampal and entorhinal cortex high-frequency oscillations (100--500 Hz) in human epileptic brain and in kainic acid--treated rats with chronic seizures. Epilepsia (1999) 3.96
High-frequency oscillations in human brain. Hippocampus (1999) 3.89
Automated labeling of the human brain: a preliminary report on the development and evaluation of a forward-transform method. Hum Brain Mapp (1997) 3.23
A new crystal structure, Ca2+ dependence and mutational analysis reveal molecular details of E-cadherin homoassociation. EMBO J (1999) 3.20
Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J (1990) 3.16
Shapes, domain organizations and flexibility of laminin and fibronectin, two multifunctional proteins of the extracellular matrix. J Mol Biol (1981) 3.15
Glossary of descriptive terminology for ictal semiology: report of the ILAE task force on classification and terminology. Epilepsia (2001) 2.90
The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel? Science (1996) 2.87
A new nomenclature for the laminins. Matrix Biol (1994) 2.82
alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem (2001) 2.77
Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry (1989) 2.67
Kinetics of the cooperative association of actin to actin filaments. Biophys Chem (1975) 2.55
Characterization of Pseudomonas aeruginosa-induced MDCK cell injury: glycosylation-defective host cells are resistant to bacterial killing. Infect Immun (1995) 2.48
Protease resistance and conformation of laminin. Eur J Biochem (1982) 2.47
Cerebral microdialysis combined with single-neuron and electroencephalographic recording in neurosurgical patients. Technical note. J Neurosurg (1999) 2.46
Electron-microscopical approach to a structural model of intima collagen. Biochem J (1983) 2.32
Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry (1992) 2.31
Chronic epileptogenesis requires development of a network of pathologically interconnected neuron clusters: a hypothesis. Epilepsia (2000) 2.31
CD133 expression is an independent prognostic marker for low survival in colorectal cancer. Br J Cancer (2008) 2.23
Conformational changes of the recombinant extracellular domain of E-cadherin upon calcium binding. Eur J Biochem (1994) 2.23
Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23
Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins. J Biol Chem (1994) 2.22
7-S collagen: characterization of an unusual basement membrane structure. Eur J Biochem (1980) 2.19
Changes in blood lymphocyte populations after multiple trauma: association with posttraumatic complications. Crit Care Med (1999) 2.18
Laminin-nidogen complex. Extraction with chelating agents and structural characterization. Eur J Biochem (1987) 2.15
Foreign body ingestion: review and suggested guidelines for management. Endoscopy (1987) 2.08
BBID: the biological biochemical image database. Bioinformatics (2000) 2.07
Homophilic adhesion of E-cadherin occurs by a co-operative two-step interaction of N-terminal domains. EMBO J (1996) 2.05
Creation and use of a Talairach-compatible atlas for accurate, automated, nonlinear intersubject registration, and analysis of functional imaging data. Hum Brain Mapp (1999) 2.03
Miltefosine for new world cutaneous leishmaniasis. Clin Infect Dis (2004) 2.02
Mapping motor representations with positron emission tomography. Nature (1994) 2.00
Single amino acid substitutions in one Ca2+ binding site of uvomorulin abolish the adhesive function. Cell (1990) 1.98
Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry (1987) 1.98
Folding mechanism of the triple helix in type-III collagen and type-III pN-collagen. Role of disulfide bridges and peptide bond isomerization. Eur J Biochem (1980) 1.96
Positron emission tomography: human brain function and biochemistry. Science (1985) 1.92
Qualitative and quantitative evaluation of six algorithms for correcting intensity nonuniformity effects. Neuroimage (2001) 1.90
Stabilization of short collagen-like triple helices by protein engineering. J Mol Biol (2001) 1.88
Thallium-201 SPECT imaging of brain tumors: methods and results. J Nucl Med (1990) 1.85
Reafferent copies of imitated actions in the right superior temporal cortex. Proc Natl Acad Sci U S A (2001) 1.85
A health-related quality of life instrument for patients evaluated for epilepsy surgery. Med Care (1992) 1.84
Electrophysiologic analysis of a chronic seizure model after unilateral hippocampal KA injection. Epilepsia (1999) 1.83
Treatment of Bolivian mucosal leishmaniasis with miltefosine. Clin Infect Dis (2006) 1.82
Outcome assessment for epilepsy surgery: the impact of measuring health-related quality of life. Ann Neurol (1995) 1.82
Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol (1980) 1.78
Structure and interactions of heparan sulfate proteoglycans from a mouse tumor basement membrane. Eur J Biochem (1984) 1.77
Domains of laminin with growth-factor activity. Cell (1989) 1.75
Acquiring simultaneous EEG and functional MRI. Clin Neurophysiol (2000) 1.75
Subunit structure and assembly of the globular domain of basement-membrane collagen type IV. Eur J Biochem (1984) 1.74
Comparative localization of epileptic foci in partial epilepsy by PCT and EEG. Ann Neurol (1982) 1.73
Diet restriction in rhesus monkeys lowers fasting and glucose-stimulated glucoregulatory end points. Am J Physiol (1995) 1.72
Three-dimensional preoperative maps of hippocampal atrophy predict surgical outcomes in temporal lobe epilepsy. Neurology (2005) 1.69
Evidence for coiled-coil alpha-helical regions in the long arm of laminin. EMBO J (1985) 1.68
Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. Am J Psychiatry (1988) 1.68
Functional anatomy of human procedural learning determined with regional cerebral blood flow and PET. J Neurosci (1992) 1.64
D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures. Epilepsy Res (1996) 1.61
[The effect of needle type and immobilization on postspinal headache]. Anaesthesist (1997) 1.59
FDG-PET/MRI coregistration improves detection of cortical dysplasia in patients with epilepsy. Neurology (2008) 1.59
Localization of flexible sites in thread-like molecules from electron micrographs. Comparison of interstitial, basement membrane and intima collagens. J Mol Biol (1984) 1.59
Macromolecular organization of natural and recombinant lung surfactant protein SP 28-36. Structural homology with the complement factor C1q. J Mol Biol (1988) 1.55
An autonomous folding unit mediates the assembly of two-stranded coiled coils. Proc Natl Acad Sci U S A (1998) 1.54
Calcium binding and homoassociation of E-cadherin domains. Biochemistry (1997) 1.54
Exchange of ADP, ATP and 1: N6-ethenoadenosine 5'-triphosphate at G-actin. Equilibrium and kinetics. Eur J Biochem (1979) 1.53
Reduced cerebral glucose metabolism in asymptomatic subjects at risk for Huntington's disease. N Engl J Med (1987) 1.51
A substitution of cysteine for glycine 748 of the alpha 1 chain produces a kink at this site in the procollagen I molecule and an altered N-proteinase cleavage site over 225 nm away. J Biol Chem (1988) 1.51
Electron microscopy and other physical methods for the characterization of extracellular matrix components: laminin, fibronectin, collagen IV, collagen VI, and proteoglycans. Methods Enzymol (1987) 1.48
Finally, a randomized, controlled trial of epilepsy surgery. N Engl J Med (2001) 1.47
Crystal structure of a naturally occurring parallel right-handed coiled coil tetramer. Nat Struct Biol (2000) 1.46
Homophilic adhesion by cadherins. Curr Opin Struct Biol (1999) 1.46
Lymphomatosis cerebri presenting as a rapidly progressive dementia: clinical, neuroimaging and pathologic findings. Dement Geriatr Cogn Disord (1999) 1.45
Brain tumors. West J Med (1991) 1.44
Pathological findings underlying focal temporal lobe hypometabolism in partial epilepsy. Ann Neurol (1982) 1.43
Magnetic resonance imaging in intractable partial epilepsy: correlative studies. Ann Neurol (1986) 1.43
Characterization of the Chlamydia trachomatis vacuole and its interaction with the host endocytic pathway in HeLa cells. Infect Immun (1997) 1.42
Extended and globular protein domains in cartilage proteoglycans. Biochem J (1987) 1.42
Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent. Clin Infect Dis (2001) 1.41
Generic substitutions for antiepileptic drugs. Neurology (1990) 1.41
The continuing challenge of primary brain tumor management: the contribution of positron emission tomography. Ann Neurol (1991) 1.40
Beneficial effect of siphoning in treatment of adult hydrocephalus. Arch Neurol (1999) 1.40
Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18. Arch Gen Psychiatry (1985) 1.39
Structure of recombinant N-terminal globule of type VI collagen alpha 3 chain and its binding to heparin and hyaluronan. EMBO J (1992) 1.38